Veloxis Pharmaceuticals, Inc., an Asahi Kasei company, is a fully integrated specialty pharmaceutical company committed to improving the lives of transplant patients. Headquartered in Cary, North Carolina, USA, Veloxis is focused on the global development and commercialization of medications utilized by transplant patients and by patients with serious related diseases. We know what transplant means to patients, and we’re leading innovation to improve their experience. For patients, transplant is a life-changing procedure. But changes come with challenges. At Veloxis, our mission is to see and respond to the challenges along the transplant journey. Read our Community Guidelines: https://bit.ly/3FQr7Wg
View Top Employees from Veloxis Pharmaceuticals, Inc.Website | https://www.veloxis.com |
Ticker | VELO |
Revenue | $39 million |
Funding | $211.7 million |
Employees | 120 (120 on RocketReach) |
Founded | 2002 |
Address | 2000 Regency Pkwy Suite 500, Cary, North Carolina 27518, US |
Phone | (919) 591-3090 |
Technologies |
JavaScript,
HTML,
PHP
+29 more
(view full list)
|
Industry | Pharmaceuticals, Biotechnology Research, Healthcare, Drug Discovery, Biotechnology, Transplant |
Web Rank | 8 Million |
Keywords | Specialty Pharmaceutical, Pharmaceutical Companies, Patient Experience, Pharmaceutical Development |
SIC | SIC Code 37 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 54 Companies, NAICS Code 541711 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Veloxis Pharmaceuticals, Inc. employee's phone or email?
The Veloxis Pharmaceuticals, Inc. annual revenue was $39 million in 2024.
Mark Hensley is the CEO of Veloxis Pharmaceuticals, Inc..
120 people are employed at Veloxis Pharmaceuticals, Inc..
Veloxis Pharmaceuticals, Inc. is based in Cary, North Carolina.
The NAICS codes for Veloxis Pharmaceuticals, Inc. are [33, 54, 541711, 541, 54171, 5417].
The SIC codes for Veloxis Pharmaceuticals, Inc. are [37, 28].